SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The sales figure stood at Rs. 3003.10 millions for the December 2024 quarter. The mentioned figure indicates a growth of about 41.70% as compared to Rs. 2119.40 millions during the year-ago period.The Total Profit for the quarter ended December 2024 of Rs. 81.00 millions grew from Rs.-2753.30 millions Operating profit Margin for the quarter ended December 2024 improved to 591.80% as compared to -1612.30% of corresponding quarter ended December 2023


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202403 202303 % Var
Sales 3003.10 2119.40 41.70 10107.50 9894.90 2.15 12889.20 14438.10 -10.73
Other Income 14.90 4.40 238.64 31.90 37.40 -14.71 53.70 221.40 -75.75
PBIDT 591.80 -1612.30 -136.71 1644.40 -1011.20 -262.62 -896.90 1561.80 -157.43
Interest 265.40 253.70 4.61 856.90 753.50 13.72 1059.70 900.60 17.67
PBDT 326.40 -2493.70 -113.09 787.50 -2427.90 -132.44 -3853.00 661.20 -682.73
Depreciation 245.40 259.60 -5.47 749.50 779.30 -3.82 1030.30 1109.00 -7.10
PBT 81.00 -2753.30 -102.94 38.00 -3207.20 -101.18 -4883.30 -447.80 990.51
TAX 0.00 0.00 0.00 0.00 -102.50 0.00 785.40 -225.70 -447.98
Deferred Tax 0.00 0.00 0.00 0.00 -102.50 0.00 785.40 -224.60 -449.69
PAT 81.00 -2753.30 -102.94 38.00 -3104.70 -101.22 -5668.70 -222.10 2452.32
Equity 402.50 360.00 11.81 402.50 360.00 11.81 360.00 360.00 0.00
PBIDTM(%) 19.71 -76.07 -125.90 16.27 -10.22 -259.20 -6.96 10.82 -164.33

Solara Active Pharma Share Price

493.70 6.40 (1.31%)
15-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1696.65
Dr. Reddys Lab 1218.30
Cipla 1226.65
Zydus Lifesciences 936.00
Lupin 2339.20
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×